Monkeypox Testing Market was valued at USD 0.8 Billion in 2022 and is projected to reach USD 1.5 Billion by 2030, growing at a CAGR of 8.6% from 2024 to 2030.
The global Monkeypox Testing Market has witnessed significant growth in recent years, driven by the increased number of reported cases and heightened awareness around emerging zoonotic diseases. As of 2024, the market's value is estimated to be in the billions, with a projected compound annual growth rate CAGR of around 12 15% over the next 5 10 years. This growth can be attributed to the increasing prevalence of monkeypox outbreaks, improved diagnostic capabilities, and advancements in testing technologies.
Key factors driving market growth include the growing demand for faster, more accurate diagnostics, the increasing adoption of PCR polymerase chain reaction and antigen based tests, and advancements in biosensor technologies. Moreover, the development of new testing kits and diagnostic methods tailored to detecting monkeypox are expected to influence the market positively, fostering widespread access to timely and efficient testing.
Furthermore, the COVID 19 pandemic highlighted the need for improved diagnostics and surveillance systems for emerging infectious diseases, fueling investments in diagnostic infrastructure. The market's expansion is also influenced by growing government initiatives and funding in response to monkeypox outbreaks, with many countries now prioritizing preparedness for zoonotic diseases.
Get an In-Depth Research Analysis of the Global Monkeypox Testing Market Size And Forecast [2025-2032]
Drivers
The primary driver of the monkeypox testing market is the surge in monkeypox cases worldwide. While the disease had been largely confined to certain regions, recent outbreaks in non endemic areas have led to increased demand for testing kits. The heightened awareness around monkeypox and other zoonotic diseases has also led to better preparedness and funding in healthcare systems globally.
Technological advancements, such as the integration of artificial intelligence AI and machine learning ML in diagnostic tools, are contributing to more efficient testing processes. These technologies enhance the speed, accuracy, and reliability of results, making testing more accessible in both endemic and non endemic regions.
Restraints
Despite the promising growth prospects, there are a few challenges limiting the market’s potential. Regulatory hurdles, particularly the approval process for new diagnostic tests, can delay the availability of novel solutions. Additionally, the high cost of advanced diagnostic equipment can be prohibitive for some healthcare providers, especially in low income and developing regions.
Supply chain disruptions, such as shortages of essential reagents, and challenges in the distribution of testing kits across various regions, also pose significant barriers to market growth. These issues were notably highlighted during the COVID 19 pandemic and may continue to affect the availability of monkeypox testing solutions in some areas.
Opportunities
The expansion of molecular and antigen based diagnostic technologies presents significant opportunities for market growth. As molecular diagnostics become more affordable and portable, the potential for increased testing in remote areas and underserved populations grows. This is especially true for real time PCR and point of care tests that offer rapid results with minimal resources.
Collaboration between government bodies, healthcare providers, and diagnostic companies to develop scalable, cost effective testing solutions is another opportunity. Public private partnerships are expected to facilitate more widespread distribution of testing kits, ensuring timely access to diagnostics across the globe. The increasing prevalence of telemedicine and digital health services is also likely to expand the reach of testing services, particularly in regions where healthcare infrastructure is limited.
By Application
The monkeypox testing market can be segmented by application, including:
Diagnostics: Diagnostic testing is the core application, including the use of PCR and antigen based tests. This segment has witnessed substantial growth due to the rising demand for fast and accurate diagnostics during outbreaks.
Surveillance: Surveillance testing is crucial for monitoring the spread of monkeypox, particularly in endemic regions. Governments and health organizations regularly employ surveillance tests to track outbreaks and implement control measures.
Research: Research labs and institutions require specialized testing to study the virus’s behavior, mutation patterns, and response to treatments. This segment is essential for advancing understanding and developing new therapeutic solutions.
By End User
The market is also segmented based on end users, which include:
Hospitals and Clinics: As the primary healthcare providers, hospitals and clinics are major consumers of monkeypox testing kits. They are responsible for conducting diagnostic tests and managing treatment plans.
Public Health Organizations: These entities play a key role in implementing surveillance strategies and managing outbreaks. They rely heavily on testing to monitor trends and control the spread of the virus.
Diagnostic Laboratories: These laboratories specialize in processing and analyzing diagnostic samples. They play a pivotal role in providing accurate test results, particularly in cases where advanced diagnostic methods like PCR are used.
By Region
The market can be broken down by region as follows:
North America: North America is a leading market due to its strong healthcare infrastructure, high demand for advanced diagnostics, and government initiatives to combat emerging infectious diseases.
Europe: Europe is also a significant market, with countries like the UK and Germany investing heavily in monkeypox testing solutions, especially during outbreaks. Regulations and strict health protocols further drive demand in the region.
Asia Pacific: The Asia Pacific region is expected to witness the highest growth rate, driven by increasing healthcare investments, rising monkeypox awareness, and improving healthcare infrastructure in countries like India, China, and Southeast Asia.
Rest of the World: The rest of the world, particularly Africa, where monkeypox is endemic, continues to be a primary region for testing. Additionally, Latin America is seeing rising demand for better diagnostics.
Major players in the monkeypox testing market include:
Abbott Laboratories: Abbott offers a variety of molecular diagnostic tests, including PCR tests for emerging viruses like monkeypox. The company’s rapid diagnostic solutions are used globally to detect infectious diseases.
Thermo Fisher Scientific: A key player in molecular diagnostics, Thermo Fisher provides a broad range of testing solutions, including reagents and systems for detecting viruses such as monkeypox.
BD Becton, Dickinson and Company: BD is another prominent player, providing diagnostic instruments and testing solutions used in laboratories and hospitals for the detection of infectious diseases.
Roche Diagnostics: Roche offers advanced diagnostic systems and reagents for various viral diseases, including PCR kits and antigen tests crucial for monkeypox detection.
BioMérieux: BioMérieux specializes in infectious disease diagnostics and offers a wide range of testing solutions that can be adapted for detecting monkeypox outbreaks.
Emerging technologies and innovations are expected to continue shaping the monkeypox testing market. Notable trends include:
Point of care Testing: Point of care POC diagnostics, which enable rapid results outside traditional lab settings, are gaining popularity due to their convenience and ability to offer results in real time. This trend is expected to increase testing capacity during outbreaks.
AI Powered Diagnostics: Artificial intelligence is being integrated into diagnostic platforms to enhance accuracy and speed in detecting monkeypox infections, reducing human error, and streamlining the testing process.
Collaboration with Health Organizations: Strategic partnerships between private companies and global health organizations are helping to expand testing availability and accessibility, particularly in under resourced regions.
Challenges facing the monkeypox testing market include:
Supply Chain Issues: The global supply chain disruptions caused by the COVID 19 pandemic have highlighted vulnerabilities in the availability of diagnostic kits and reagents. Ensuring a stable supply chain is crucial for timely testing during outbreaks.
High Costs: Advanced diagnostic tools like PCR testing kits can be expensive, limiting access in low income regions. Solutions such as subsidies and affordable testing alternatives can help alleviate this issue.
Regulatory Barriers: Regulatory approvals for new diagnostic methods can be time consuming, delaying the introduction of innovative solutions. Streamlining regulatory processes will be key to accelerating the availability of new testing technologies.
The future of the monkeypox testing market looks promising, with continued growth expected over the next 5 10 years. Key factors driving this evolution include increased surveillance efforts, advancements in molecular diagnostics, and rising investments in public health preparedness. Governments and healthcare organizations are expected to continue prioritizing infectious disease management, creating opportunities for further market development.
Additionally, the expansion of global healthcare infrastructure, particularly in emerging markets, will drive demand for more accessible, affordable diagnostic solutions. With increasing collaboration between public and private sectors, the monkeypox testing market is expected to grow in both developed and developing regions.
Which regions are leading the monkeypox testing market? North America, Europe, and Africa are currently leading the market due to strong healthcare systems and the prevalence of monkeypox in endemic regions.
What are the key applications in the monkeypox testing market? The key applications are diagnostics, surveillance, and research, each contributing to the market's growth through various healthcare and research initiatives.
What are the major challenges in the monkeypox testing market? Key challenges include supply chain disruptions, high costs of testing, and regulatory hurdles that may delay the introduction of new solutions.
Which companies are leading the monkeypox testing market? Major players include Abbott Laboratories, Thermo Fisher Scientific, BD, Roche Diagnostics, and BioMérieux.
What is the future growth potential of the monkeypox testing market? The market is expected to grow significantly over the next decade, driven by technological advancements, increased awareness, and the need for more accessible testing solutions globally.
Aegis Sciences Corp.
Laboratory Corp. of America Holdings
Quest Diagnostics
Inc.
Sonic Healthcare Ltd.
QIAGEN
Mayo Clinic Laboratories
Chembio Diagnostics
Inc.
Sonora Quest Laboratories
Thermo Fisher Scientific
BD
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Monkeypox Testing Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Monkeypox Testing Market
Hospitals & Clinics
Diagnostic Laboratories
Others
Based on Types the Market is categorized into Below types that held the largest Monkeypox Testing market share In 2023.
Polymerase Chain Reaction (PCR)
Lateral Flow Assay (LFA)
Others
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Monkeypox Testing Market Research Analysis
1. Introduction of the Global Monkeypox Testing Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Monkeypox Testing Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Monkeypox Testing Market, By Type
6. Global Monkeypox Testing Market, By Application
7. Global Monkeypox Testing Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Monkeypox Testing Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/